Latest Revenue Guidance News

Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.

Fluence Corporation reported a robust Q1 2025 with revenue surging 64.5% year-over-year, driven by the Ivory Coast Addendum project, while EBITDA turned positive for the first time in over a year. The company maintains its full-year guidance despite tariff uncertainties.

Fluence Corporation Limited reported a robust 64.5% revenue increase in Q1 2025, driven by a strategic pivot to higher-margin Smart Product Solutions and recurring revenue streams, while maintaining its full-year guidance.

Nova Eye Medical reported a 27% rise in Q3FY25 sales excluding China, driven by record US performance and a sharp reduction in glaucoma segment losses. The company confirmed FY25 revenue guidance and unveiled plans to expand its iTrack™ technology into ocular drug delivery.

Aroa Biosurgery reports a second consecutive quarter of positive operating cash flow and record sales for its Myriad product line, while maintaining full-year FY25 revenue and EBITDA guidance.

Atturra Limited reports a robust first half of FY25 with revenue growth nearing 28%, driven by recent acquisitions and expanding service offerings, while updating full-year guidance amid cautious government sector risks.

SEEK Limited’s FY2025 half-year results reveal a revenue dip and profit contraction, yet the company delivers a robust free cash flow surge and raises its interim dividend, underscoring resilience amid evolving market conditions.

Infomedia Ltd delivered a robust first half FY25 with a 63% jump in net profit after tax and a 7% rise in underlying cash EBITDA, despite challenges in its SimplePart e-commerce segment. The company’s strategic acquisition of AI specialist Intellegam signals a bold push into data-driven automotive solutions.

Infomedia Ltd reported a steady 2% revenue increase and an 11% rise in NPATA for H1 FY25, alongside a strategic 50% stake acquisition in European AI startup Intellegam, signaling a push for innovation and global expansion.

Findi Limited has expanded its ATM footprint with the State Bank of India by 54%, securing 2,293 additional ATMs and appointing Rothschild & Co for its 2026 Indian IPO. However, FY25 revenue guidance has been revised down due to delays in White Label ATM license commencement.

The a2 Milk Company has reported robust first-half FY25 results, boosting full-year guidance and declaring its inaugural dividend, underscoring confidence in its growth trajectory.

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.